Key Insights

Highlights

Success Rate

82% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

9.5%

2 terminated out of 21 trials

Success Rate

81.8%

-4.7% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

22%

2 of 9 completed with results

Key Signals

2 with results82% success

Data Visualizations

Phase Distribution

17Total
Not Applicable (7)
P 1 (4)
P 2 (6)

Trial Status

Completed9
Unknown5
Recruiting3
Not Yet Recruiting2
Terminated2

Trial Success Rate

81.8%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (21)

Showing 20 of 20 trials
NCT06615830Not Yet RecruitingPrimary

Predictive Value of Transcriptome-based OncoTreat/Oncotarget and Organoid Testing in Metastatic Pancreatic Cancer.

NCT07173257RecruitingPrimary

PROMs After Pancreatectomy

NCT02905578Phase 2Completed

A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1)

NCT06914349Not ApplicableRecruiting

Antecolic Versus Retrocolic Gastrojejunostomy During Whipple's Procedure

NCT06981273Not ApplicableNot Yet RecruitingPrimary

Robotic vs Open Pancreatoduodenectomy

NCT06980792CompletedPrimary

Surgical Approach for Adenocarcinoma of the Pancreas With Synchronous Liver Metastases

NCT06947395Completed

Clinical Validation of a Blood Biomarker Test to Detect Early-Stage Pancreatic Cancer (VERIFI)

NCT06757244Phase 2RecruitingPrimary

DOVIPA, a Study Evaluating Efficacy and Safety of DOstarlimab and VItamin D3 With mFOLFIRINOX in PAncreatic Cancer

NCT02681796Phase 1Completed

Epidural Analgesia Use in Pancreatic Resections

NCT03803930Not ApplicableUnknownPrimary

Comparing of a 22G EUS Procore Fine Needle Biopsy Device and a 20G EUS Procore Fine Needle Biopsy Device

NCT01693419Phase 2CompletedPrimary

S-1, Gemcitabine and Erlotinib for Advanced Pancreatic Cancer

NCT02789371Not ApplicableUnknownPrimary

Comparing of Modified Wet Suction Technique and Dry Suction Technique for EUS-FNA of Solid Occupying Lesions

NCT01446458Phase 1Completed

Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer

NCT00198081Phase 2TerminatedPrimary

Use of Celecoxib in Patients With Intraductal Papillary Mucinous Neoplasms (IPMNs)

NCT02327065Not ApplicableUnknownPrimary

Prospective Multi-center, Single Blinded, Randomized, Controlled Trial of EUS-FNB and EUS-FNA on Solid Occupying Lesion

NCT00930410Not ApplicableCompletedPrimary

Intra-ductal Confocal Endomicroscopy for Characterization of Pancreas and Bile Duct Tumor

NCT01774162Not ApplicableCompleted

EUS-guided Fine Needle Biopsy With a New Core Histology Needle Versus Conventional Fine Needle Aspiration

NCT00683085Phase 1Terminated

Human Leukocyte Antigen-A*02:01-restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer

NCT00690300Phase 2UnknownPrimary

Docetaxel Plus Oxaliplatin as Therapy in Patients With Pancreatic Cancer

NCT00683358Phase 1Unknown

Human Leukocyte Antigen-A*2402-Restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer

Scroll to load more

Research Network

Activity Timeline